Skip to content
CompanySight
Company No. 04135806 · Incorporated 4 Jan 2001

Arena Pharmaceuticals Limited

Registered name: ARENA PHARMACEUTICALS LIMITED

Part of Imcd N.V. group

Arena Pharmaceuticals Limited made £4.5m revenue and £394k profit in the year to 31 Jan 2026.

Arena Pharmaceuticals Limited’s revenue fell 12% to £4.5m in the year to 31 Jan 2026, with £394k profit and 3 employees. The company is classified under “wholesale of pharmaceutical goods” and is based in Buckingham; we hold 4 years of its filed accounts.

Full P&L filedSection G · Wholesale and retail trade; repair of motor vehiclesSIC 46460Wholesale of pharmaceutical goods
Status
Active
Location
Buckingham, South East
Age
25 yrs · since 2001
Type
Private Limited Company

Part of a group. The filing indicates this company sits within a group structure, so its results may depend on intra-group trading and it may be hard to replicate independently.

Latest accounts · year to 31 Jan 2026

Key figures

Small team
Revenue
£4.5m
Growth ▼11.9%
Profit
£394k
Growth ▲37.1%
Profit margin
8.7%
Gross 16.6%
Employees
3
Change ▲50%
Profit / employee
£131k
Revenue/employee £1.5m
Profitable streak
3yrs
Consecutive profitable years in our data

Badges are automated estimates derived from the filed figures — not statements of fact about the company.

4 filed years

Financial history

Multi-year financials, oldest to newest
Year to31 Jan 202331 Jan 202431 Jan 202531 Jan 2026
DisclosureNo P&LFull P&LFull P&LFull P&L
Profit & loss
Revenue (turnover)—£5.7m£5.1m£4.5m
Cost of sales—−£4.8m−£4.5m−£3.8m
Gross profit—£830k£660k£751k
Operating profit—£474k£408k£511k
Profit before tax—£474k£408k£501k
Profit after tax—£389k£287k£394k
Profit (best available)—£389k£287k£394k
Employees (average)2223
Ratios
Profit margin—6.9%5.6%8.7%
Gross margin—14.6%12.8%16.6%
Revenue per employee—£2.8m£2.6m£1.5m
Profit per employee—£195k£144k£131k
Growth (year on year)
Revenue growth——▼9.3%▼11.9%
Profit growth——▼26.2%▲37.1%
Headcount growth—0%0%▲50%
Balance sheet — indirect signals, not revenue
Cash at bank£712k£1.3m——
Net assets£1.2m£1.4m——
Fixed assets£3.6k£2.6k——
Current assets£2.3m£2.6m——
Debtors£775k£747k——
SourceAccounts · bulk data May 2024Accounts · bulk data May 2024Accounts · bulk data Sep 2025Accounts · bulk data Sep 2026
Derived from the latest filing

How the business works

Profit margin
8.7%
Profit ÷ revenue.
Gross margin
16.6%
Gross profit ÷ revenue. High for software and services.
Revenue per employee
£1.5m
Revenue ÷ average employees.
Profit per employee
£131k
Profit ÷ average employees.
Cash conversion
—
Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
Fixed assets ÷ revenue
—
Capital intensity. Low = capital-light, cheaper to start.
Deferred income ÷ revenue
—
Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
Debtors ÷ revenue
—
Money owed by customers. Low = customers pay quickly.
Indirect — not revenue

Balance-sheet signals

Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.

Net assets
—
Now —
Cash at bank
—
Now —
Headcount
▲50%
Now 3
Deferred income
—
Now —
Fixed assets
—
Now —
Corporate ownership

Group structure

Ownership chain

  1. Imcd N.V. (registered outside the UK register)ultimate parent75–100%
  2. Imcd UK Acquisitions Limited75–100%
  3. Imcd UK Limited75–100%
  4. Pethel Marali Limited75–100%
  5. Arena Pharmaceuticals Limitedthis company

Bands show the share of ownership each company holds in the one below it.

From the Persons with Significant Control register (corporate controllers only).

Same industry, similar size

Similar profitable businesses

Industry benchmarks →

Sources

Latest figures from accounts for the year to 31 Jan 2026 (profit £394k), from the Companies House accounts bulk data published Sep 2026. Spotted an error? Request a correction.

Updated from Companies House on 14 Oct 2026

Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.